Biomarkers in Neurodegenerative Diseases
This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some...
Zapisane w:
| Kolejni autorzy: | |
|---|---|
| Format: | Elektroniczne Rozdział |
| Język: | angielski |
| Wydane: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Hasła przedmiotowe: | |
| Dostęp online: | DOAB: download the publication DOAB: description of the publication |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_95798 | ||
| 005 | 20230105 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230105s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-5730-4 | ||
| 020 | |a 9783036557298 | ||
| 020 | |a 9783036557304 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-5730-4 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Ghosh, Arnab |4 edt | |
| 700 | 1 | |a Ghosh, Arnab |4 oth | |
| 245 | 1 | 0 | |a Biomarkers in Neurodegenerative Diseases |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (190 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future. The original research work and review articles published here highlight some unique mechanisms underlying the most prevalent pathophysiological conditions affecting human health. Other areas covered in the book include emerging treatment options and correct diagnoses using different biochemical and imaging techniques. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a Alzheimer's disease | ||
| 653 | |a amyloid beta | ||
| 653 | |a hippocampus | ||
| 653 | |a Kir channels | ||
| 653 | |a K+ channels | ||
| 653 | |a glioblastoma multiforme | ||
| 653 | |a low-grade glioma | ||
| 653 | |a astrocytoma | ||
| 653 | |a recurrence | ||
| 653 | |a multifocal growth | ||
| 653 | |a mRNA expression | ||
| 653 | |a MPS1 | ||
| 653 | |a TTK | ||
| 653 | |a therapy | ||
| 653 | |a EDTA chelation therapy | ||
| 653 | |a neurodegenerative diseases | ||
| 653 | |a metal detoxification | ||
| 653 | |a reactive oxygen species (ROS) | ||
| 653 | |a neuroinflammation | ||
| 653 | |a neurodegeneration | ||
| 653 | |a cognitive dysfunction | ||
| 653 | |a neurofibrillary tangles | ||
| 653 | |a diagnosis methods | ||
| 653 | |a biomarkers | ||
| 653 | |a perinatal stress | ||
| 653 | |a NURR1 | ||
| 653 | |a inflammation | ||
| 653 | |a late-onset diseases | ||
| 653 | |a early life | ||
| 653 | |a artificial neural network | ||
| 653 | |a deep learning | ||
| 653 | |a Parkinson's disease | ||
| 653 | |a atypical parkinsonian syndrome | ||
| 653 | |a dopamine transporter SPECT | ||
| 653 | |a β-Amyloid | ||
| 653 | |a calpain | ||
| 653 | |a Collapsin Response Mediator Protein-2 | ||
| 653 | |a human-neuroblastoma SH-SY5Y cells | ||
| 653 | |a Somatostatin-14 | ||
| 653 | |a somatostatin receptor | ||
| 653 | |a brain injury | ||
| 653 | |a quinpirole | ||
| 653 | |a dopamine D2 receptors | ||
| 653 | |a glial cell | ||
| 653 | |a autophagy | ||
| 653 | |a mitophagy | ||
| 653 | |a multiple sclerosis | ||
| 653 | |a biomarker | ||
| 653 | |a neurons | ||
| 653 | |a astrocytes | ||
| 653 | |a Alzheimer's and Parkinson's diseases | ||
| 653 | |a fluid and imaging biomarkers | ||
| 653 | |a amyloid-β and tau | ||
| 653 | |a miRNA | ||
| 653 | |a extracellular vesicles | ||
| 653 | |a exosomes and ectosomes | ||
| 653 | |a PET | ||
| 653 | |a radiotracers | ||
| 653 | |a radiolabeled molecules | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6454 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/95798 |7 0 |z DOAB: description of the publication |